In the Boardroom
Refine Search
Pharmaceutical
German drugmaker Grünenthal has named Maren Thurow as its new vice president and head of global communications, stepping into the role at a time of significant business expansion and leadership change. She succeeds Florian Dieckmann, who had led the company’s communications function since 2021. 20 May 2025
Biotechnology
Shares in Prime Medicine, a US biotech seeking to develop one-time curative genetic therapies, closed 16% lower Monday. 20 May 2025
Biotechnology
Genetic medicines company Arbor Biotechnologies has announced the appointment of Don Haut as chief business officer. 19 May 2025
Pharmaceutical
Danish diabetes and weight loss juggernaut Novo Nordisk is to part ways with its chief executive Lars Fruergaard Jørgensen as the group seeks to reverse its fortunes. 16 May 2025
Pharmaceutical
USA-based Inozyme Pharma, a biopharma developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, has a new chief medical officer (CMO). 15 May 2025
Biotechnology
Compugen, an Israeli cancer immunotherapy company that calls itself a pioneer in computational target discovery, has announced key leadership transitions to take effect in September 2025 following the firm’s annual general meeting. 13 May 2025
Biotechnology
Swedish biotech Hansa Biopharma has appointed Maria Törnsén as chief operating officer and president US, strengthening its commercial leadership ahead of key milestones for its kidney transplant drug Idefirix (imlifidase). 13 May 2025
Biotechnology
Boston, USA-based biotech Aera Therapeutics, which is harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, today announced the appointment of Paul Conrad as chief business and financial officer. 12 May 2025
Pharmaceutical
US pharma major Eli Lilly yesterday announced executive leadership transitions that will further enhance the company's ability to drive sustained, long-term growth and ensure that its medicines continue to reach millions of people worldwide. 9 May 2025
Biotechnology
US regenerative medicine firm Forever Labs has formally spun out SuperShot as a standalone business, a move the company says will allow both entities to sharpen their focus on growth and innovation. 8 May 2025
Pharmaceutical
UK-based specialty pharma business Kelso Pharma has appointed Bee Koen Low as its first chief operating officer (COO). 8 May 2025
Biotechnology
Privately-held Italian firm Sibylla Biotech today announced the appointment of Dieter Weinand as chairman of its board of directors. 8 May 2025
Biotechnology
Priothera today announced the appointment of Jens Hasskarl, as its chief medical officer (CMO). 6 May 2025
Biotechnology
Sweden’s Mendus, a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief medical officer, effective today, May 5. 5 May 2025
Biotechnology
Cidara Therapeutics, a San Diego biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) therapeutics, has announced that Nicole Davarpanah has been promoted to chief medical officer (CMO). 2 May 2025
Biotechnology
US biotech Akari Therapeutics, which is developing novel payload antibody drug conjugates (ADCs), today announced the appointment of Mark Kubik as head of business development - oncology. 1 May 2025
Biotechnology
Enara Bio, a privately-held UK biopharma developing bispecific T-cell engagers, has announced the appointment of Stacey Davis as chief business officer (CBO) and chief financial officer (CFO). 1 May 2025
Pharmaceutical
US biotech Transneural Therapeutics has named industry veteran Mark Demitrack as its chief research and development officer, as the company prepares to move its lead candidate for depression and PTSD into the clinic. 30 April 2025
Biotechnology
Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes alongside an international expansion drive, under the ownership of investment firm EdgeCap Partners. 28 April 2025
Pharmaceutical
Israel-based Medison, a creator of a first-of-its-kind unified global commercialization platform that accelerates the launch of breakthrough therapies, has announced two key additions to its global leadership team: Shay Tamari as chief business officer (CBO) and Tali Mirsky as chief legal and compliance officer (CLCO). 19 June 2025
Pharmaceutical
Australian biotech PolyActiva has brought in seasoned pharma executive Jerry St Peter as chief executive, in a leadership shake-up timed with a fresh $25 million financing round and a push to commercialize its lead eye implant therapy in the USA. 19 June 2025
Biotechnology
Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, effective immediately. 17 June 2025
Biotechnology
Boston, USA-based biotech Solu Therapeutics today announced the appointment of Enda Moran as chief operating officer (COO). 16 June 2025
Pharmaceutical
Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organization (CMO) specializing in sterile manufacture of injectable drug products, has appointed Angelika Rublack as senior business development manager to support its expanding global client base and drive growth across several territories. 13 June 2025
Biotechnology
US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a member of its board of directors. 11 June 2025
Pharmaceutical
UK-based microbiome company Microbiotica has appointed Robert Tansley its chief medical officer (CMO). 10 June 2025
Biotechnology
Swiss pharma company Idorsia today announced the appointment of Dr Srishti Gupta as chief executive (CEO), effective July 1, 2025. 10 June 2025
Biotechnology
US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding retinal diseases, has appointed Daniel Chung as chief medical officer (CMO). 9 June 2025
Biotechnology
France-based SparingVision, a genomic medicine company focused on the treatment of retinal disease, has announced the appointment of Kalliopi ‘Kali’ Stasi, as chief medical officer, effective immediately. 9 June 2025
Pharmaceutical
UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease R&D. 9 June 2025
Pharmaceutical
US cardiorenal-focussed drugmaker Ardelyx announced that Mike Kelliher, formerly executive vice president, corporate development and strategy, has been promoted to chief business officer, and James Brady has joined the company as chief human resources officer. 6 June 2025
Pharmaceutical
Danish dermatology specialist LEO Pharma has appointed Helle Hedegaard Juhl as executive vice president for global people and corporate affairs (GPCA). 4 June 2025
Biotechnology
Netherlands-based biotech VectorY Therapeutics, which is developing treatments for neurodegenerative diseases, today announced the appointment of Jessica Atkinson as Chief Business Officer (CBO). 2 June 2025
Pharmaceutical
Swiss biotech iOnctura has appointed Steven Sciuto as chief financial officer and Michelle Tsai as chief operating officer, marking a leadership shift as the company moves deeper into Phase II trials for its lead cancer candidate, roginolisib (IOA-244). 2 June 2025
Pharmaceutical
US biotech Hillstar Bio has appointed Maude Tessier as chief operating officer and Shiva Krupa as vice president of program management, reinforcing its leadership bench ahead of a planned clinical entry for its lead autoimmune program in 2026. 29 May 2025
Biotechnology
Swedish biotech Hansa Biopharma is preparing to reduce its headcount by around one-fifth as part of a restructuring plan aimed at sharpening operational focus and reducing costs. 27 May 2025
Pharmaceutical
Danish privately-held drugmaker MC2 Therapeutics today announced the appointment of Trine Ahlgreen as chief executive (CEO). 27 May 2025
Biotechnology
UK biotech Nucleome Therapeutics has appointed Bhavna Hunjan as chief business officer, a move that strengthens its leadership as it advances its pipeline of antibody therapies for inflammatory diseases. 27 May 2025
Pharmaceutical
USA-based nonprofit CureDuchenne has announced the appointment of Brenda Wong as its new chief medical advisor (CMA), effective January 5, 2026. 22 May 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze